CY1509A - Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin - Google Patents

Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin

Info

Publication number
CY1509A
CY1509A CY1509A CY150983A CY1509A CY 1509 A CY1509 A CY 1509A CY 1509 A CY1509 A CY 1509A CY 150983 A CY150983 A CY 150983A CY 1509 A CY1509 A CY 1509A
Authority
CY
Cyprus
Prior art keywords
heparin
pharmaceutical compositions
ergot alkaloid
hydrogenated ergot
hydrogenated
Prior art date
Application number
CY1509A
Other languages
English (en)
Inventor
Hans Buhlmann
Dieter Welzel
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CY1509A publication Critical patent/CY1509A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY1509A 1982-12-10 1983-12-07 Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin CY1509A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3245695 1982-12-10

Publications (1)

Publication Number Publication Date
CY1509A true CY1509A (en) 1990-08-03

Family

ID=6180290

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1509A CY1509A (en) 1982-12-10 1983-12-07 Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin

Country Status (25)

Country Link
JP (1) JPH0672101B2 (da)
AT (1) AT382514B (da)
AU (1) AU570658B2 (da)
BE (1) BE898356A (da)
CA (1) CA1224416A (da)
CH (1) CH656533A5 (da)
CY (1) CY1509A (da)
DD (1) DD215469B3 (da)
DK (1) DK162475C (da)
FR (1) FR2537435B1 (da)
GB (1) GB2131691B (da)
GR (1) GR79745B (da)
HK (1) HK23290A (da)
HU (1) HU190513B (da)
IE (1) IE56366B1 (da)
IL (1) IL70406A (da)
IT (1) IT1172368B (da)
LU (1) LU85127A1 (da)
NL (1) NL8304221A (da)
NZ (1) NZ206523A (da)
PH (1) PH23451A (da)
PT (1) PT77803B (da)
SE (1) SE468973B (da)
SG (1) SG53989G (da)
ZA (1) ZA839200B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432661A1 (de) * 1984-09-05 1986-03-06 Albert Prof. Dr. 6907 Nußloch Landsberger Carcinom-therapeutikum
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1245761B (it) * 1991-01-30 1994-10-14 Alfa Wassermann Spa Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE441142B (sv) * 1975-12-04 1985-09-16 Sandoz Ag Forfarande for framstellning av ett terapeutiskt preparat med antitrombotiska egenskaper
DE2554533C3 (de) * 1975-12-04 1984-08-30 Sandoz-Patent-Gmbh, 7850 Loerrach Verwendung von Dihydroergotamin und Heparin
DE2809618A1 (de) * 1978-03-06 1979-09-20 Sandoz Ag Neues therapeutisches praeparat und verfahren zu dessen herstellung
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
DE2945636A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Stabile loesungen von hydrierten ergotalkaloiden bzw. ihren salzen und heparin bzw. seinen salzen sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
SE8306792D0 (sv) 1983-12-08
JPS59116222A (ja) 1984-07-05
IE56366B1 (en) 1991-07-03
HUT34124A (en) 1985-02-28
DD215469B3 (de) 1988-03-09
IL70406A (en) 1988-08-31
IT8349456A0 (it) 1983-12-07
DK162475C (da) 1992-05-11
PT77803A (en) 1984-01-01
CH656533A5 (de) 1986-07-15
JPH0672101B2 (ja) 1994-09-14
FR2537435B1 (fr) 1987-03-20
PH23451A (en) 1989-08-07
DK565783D0 (da) 1983-12-08
IT1172368B (it) 1987-06-18
HK23290A (en) 1990-04-06
PT77803B (en) 1986-04-17
SG53989G (en) 1989-12-29
AU2222183A (en) 1984-06-14
SE468973B (sv) 1993-04-26
AT382514B (de) 1987-03-10
DD215469A5 (de) 1984-11-14
GB2131691B (en) 1986-12-03
GB2131691A (en) 1984-06-27
BE898356A (fr) 1984-06-04
HU190513B (en) 1986-09-29
NL8304221A (nl) 1984-07-02
GR79745B (da) 1984-10-31
IE832896L (en) 1984-06-10
DK565783A (da) 1984-06-11
LU85127A1 (fr) 1984-10-22
AU570658B2 (en) 1988-03-24
GB8332653D0 (en) 1984-01-11
SE8306792L (sv) 1984-06-11
FR2537435A1 (fr) 1984-06-15
ZA839200B (en) 1985-07-31
DK162475B (da) 1991-11-04
ATA428483A (de) 1986-08-15
IL70406A0 (en) 1984-03-30
CA1224416A (en) 1987-07-21
NZ206523A (en) 1987-04-30

Similar Documents

Publication Publication Date Title
IL73877A (en) Quinolone derivatives and pharmaceutical compositions containing them
IL75326A0 (en) Quinolone derivatives and pharmaceutical compositions containing them
GB2109795B (en) Ergot peptide alkaloids, their preparation and pharmaceutical compositions containing them
NZ209064A (en) N 6 -diarylalkyl-adenosine derivatives and pharmaceutical compositions
NZ206636A (en) Pyridine derivatives and pharmaceutical compositions
PH20168A (en) 7-carboxymethoxyphenylacetamino-3-cephem derivatives and their pharmaceutical compositions
IL73508A (en) Milbemycin 5-carbonate derivatives and pharmaceutical compositions containing the same
DE3373623D1 (en) Pharmaceutical combination composition and associated method
IL68496A0 (en) Ergoline derivatives,their preparation and pharmaceutical compositions containing them
NZ198414A (en) Quinolone derivatives and pharmaceutical compositions
CY1509A (en) Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin
NZ205732A (en) Thiatriazine derivatives and pharmaceutical compositions
PH20385A (en) Ergot alkaloids, compositions containing the same and method of use thereof
NZ203649A (en) 2-beta-d-ribofuranosylselenazole-4-carboxamide derivatives and pharmaceutical compositions
PH17494A (en) New ergoline derivatives and pharmaceutical compositions thereof
NZ212946A (en) Quinoline derivatives and pharmaceutical compositions
SG49185G (en) Pharmaceutical compositions containing an ergot alkaloid and heparin
GB8303475D0 (en) Ergot alkaloids
NZ195943A (en) Rifamycin derivatives and pharmaceutical compositions
PH17426A (en) Benzoquinolizines possessing high presynapticadrenoceptor antagonistic activity and pharmaceutical compositions
GB2115811B (en) Ergot alkaloids
HK3083A (en) Pharmaceutical compositions containing an ergot alkaloid and heparin
NZ213964A (en) Ergoline derivatives and pharmaceutical compositions
ZA83955B (en) Ergot alkaloids
IL67917A0 (en) Ergot alkaloids,their production and pharmaceutical compositions containing them